首页> 外文期刊>Internal and Emergency Medicine >Colorectal cancer and risk of atrial fibrillation and flutter: a population-based case–control study
【24h】

Colorectal cancer and risk of atrial fibrillation and flutter: a population-based case–control study

机译:大肠癌与房颤和扑动的风险:一项基于人群的病例对照研究

获取原文
获取原文并翻译 | 示例
           

摘要

Colorectal cancer has recently been associated with an increased atrial fibrillation risk, but evidence is very sparse. So, we conducted a population-based case–control study in northern Denmark (population 1.7 million) during 1998–2006 to estimate the atrial fibrillation/flutter risk in colorectal cancer patients. We identified 28,333 atrial fibrillation/flutter cases and 283,260 sex-, age-, and county-matched population controls. We searched the databases for a prior colorectal cancer diagnosis, a prior cancer diagnosis other than colorectal cancer, and performance of surgery within 30 days prior to atrial fibrillation/flutter. We used conditional logistic regression to estimate the OR of atrial fibrillation/flutter in patients with colorectal cancer, cancers other than colorectal and in patient with surgery. Among cases, 0.59% (n = 168) had a colorectal cancer diagnosis within 90 days before their atrial fibrillation/flutter diagnosis, compared with 0.05% (n = 155) of controls (adjusted OR = 11.8; 95% CI 9.3–14.9). Beyond the first 90 days after a colorectal cancer diagnosis, atrial fibrillation/flutter risk was no longer increased. There was likewise an increased atrial fibrillation/flutter risk in patients diagnosed with another cancer form in the prior 90 days (OR = 7.0, 95% CI 6.3–7.8). Furthermore, the atrial fibrillation/flutter risk was elevated fivefold in patients who had undergone surgery, whether or not cancer-related. We therefore conclude that colorectal cancer patients are at increased atrial fibrillation/flutter risk exclusively in the first 90 days after cancer diagnosis, but to no greater an extent than are patients with other cancers. The performance of surgery probably plays an important role in this association.
机译:大肠癌最近与房颤风险增加有关,但是证据很少。因此,我们在1998-2006年间在丹麦北部(人口170万)进行了一项基于人群的病例对照研究,以评估结直肠癌患者的房颤/扑动风险。我们确定了28,333例房颤/扑动病例和283,260例性别,年龄和县匹配的人群对照。我们在数据库中搜索了先前的大肠癌诊断,除大肠癌以外的先前癌症诊断以及房颤/扑动前30天内的手术表现。我们使用条件对数回归来估计结直肠癌,除结直肠癌以外的癌症患者和手术患者的房颤/扑动的OR。在这些病例中,有0.59%(n = 168)在房颤/扑出物诊断前90天内诊断为大肠癌,而对照组为0.05%(n = 155)(校正OR = 11.8; 95%CI 9.3-14.9)。 。诊断结直肠癌后的前90天,房颤/扑动的风险不再增加。在过去90天内被诊断患有另一种癌症的患者,其心房颤动/扑动的风险也同样增加(OR = 7.0,95%CI 6.3-7.8)。此外,无论是否与癌症相关,接受过手术的患者的房颤/扑动风险都增加了五倍。因此,我们得出结论,结肠直肠癌患者仅在癌症诊断后的前90天内房颤/扑动风险增加,但程度不超过患有其他癌症的患者。手术的表现可能在这种关联中起着重要作用。

著录项

  • 来源
    《Internal and Emergency Medicine》 |2012年第5期|p.431-438|共8页
  • 作者单位

    Department of Clinical Epidemiology, Aarhus University Hospital, Olof Palmes Allé 43-45, 8200, Aarhus N, Denmark;

    Department of Clinical Epidemiology, Aarhus University Hospital, Olof Palmes Allé 43-45, 8200, Aarhus N, Denmark;

    Department of Clinical Epidemiology, Aarhus University Hospital, Olof Palmes Allé 43-45, 8200, Aarhus N, Denmark;

    Department of Epidemiology, University of Washington, 1959 NE Pacific Street, Health Sciences F-262D, Seattle, WA, USA;

    Department of Medicine, University of North Carolina, School of Medicine, 4160-A Bioinformatics Bldg Mason Farm Road, Chapel Hill, NC, 27599-7555, USA;

    Department of Clinical Epidemiology, Aarhus University Hospital, Olof Palmes Allé 43-45, 8200, Aarhus N, Denmark;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Arrhythmia; Atrial flutter; Case–control; Colorectal neoplasm; Fibrillation;

    机译:心律失常;心房扑动;病例对照;大肠肿瘤;心律失常;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号